alogliptin vs linagliptin
Side-by-side comparison of alogliptin and linagliptin Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Nesina
Tradjenta
Alogliptin and Metformin HCl is a drug that helps lower blood sugar in adults with type 2 diabetes. It works along with diet and exercise.
Jentadueto XR is a drug that combines linagliptin and metformin. It helps lower blood sugar in adults with type 2 diabetes, along with diet and exercise.
This medicine is used to treat type 2 diabetes. It helps to control your blood sugar levels when used with diet and exercise. It is not for use in type 1 diabetes.
Jentadueto XR is used to improve blood sugar control in adults with type 2 diabetes. It should be used in addition to diet and exercise. It is not for people with type 1 diabetes. It has not been studied in patients with a history of pancreatitis.
Alogliptin helps your body release more insulin after you eat. Metformin helps your body use insulin better and lowers the amount of sugar your liver makes. Together, they help lower your blood sugar levels.
This medicine contains two drugs. Linagliptin helps your body release more insulin after you eat. Metformin helps your body use insulin better and reduces sugar production in the liver.
- • Upper respiratory tract infection
- • Common cold
- • Diarrhea
- • High blood pressure
- • Headache
- • Runny nose or sore throat
- • Diarrhea
- Diarrhea 134
- Feeling sick to your stomach 124
- Throwing up 110
- Sudden kidney damage 101
- Blistering skin condition 101
- High blood sugar 1,326
- Diarrhea 1,196
- Nausea 1,138
- Tiredness 1,028
- Difficulty breathing 998
This medicine can cause a serious condition called lactic acidosis. Symptoms include feeling very sick, muscle pain, trouble breathing, sleepiness, and stomach pain. Get medical help right away if you have these symptoms. Certain conditions increase your risk, including kidney problems, taking certain other medicines, being 65 or older, and drinking a lot of alcohol.
Jentadueto XR can cause a serious side effect called lactic acidosis. This is a buildup of lactic acid in your blood. Get medical help right away if you have symptoms like weakness, muscle pain, trouble breathing, stomach pain, dizziness, or a slow or irregular heartbeat. Certain conditions increase your risk, such as kidney problems, drinking a lot of alcohol, or having surgery.
Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if this medicine will harm your unborn baby. Discuss the risks and benefits with your doctor. Also, tell your doctor if you are breastfeeding.
Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if Jentadueto XR will harm your unborn baby. Discuss the best way to control your blood sugar during pregnancy with your doctor.
Also Compare — Nearby Drugs
Compare alogliptin with
Compare linagliptin with
How to Read This alogliptin vs linagliptin Comparison
alogliptin is classified in the DPP-4 Inhibitor drug class, while linagliptin sits within the DPP-4 Inhibitor class. Because both drugs share the same classification, they are often considered interchangeable in theory — but clinical outcomes rarely track that cleanly. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, alogliptin has 570 submissions while linagliptin has 5,686. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between alogliptin and linagliptin — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.